Clinical Trials Logo

Clinical Trial Summary

The goal of this observational study is to analyze the characteristics of left atrial electroanatomical maps in patients without a history of atrial fibrillation but with a high clinical risk of developing it, as indicated by the presence of structural heart disease or a CHA2DS2-VASc score ≥ 2 points. The study cohort will be compared to a historical cohort of patients with diagnosed atrial fibrillation in a propensity-matched fashion. The main questions it aims to answer are: - Are the left atrial electroanatomical changes a consequence or a precursor to the development of atrial fibrillation? - Are the left atrial electroanatomical findings different between patients with atrial fibrillation and those at high risk of developing it? - What is the prognostic impact of left atrial pathologic changes in patients without diagnosed atrial fibrillation in terms of cardiovascular outcomes?


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06425822
Study type Observational
Source Universitair Ziekenhuis Brussel
Contact Andrea Sarkozy, MD, PhD
Phone 0032 02476 3657
Email Andrea.Sarkozy@uzbrussel.be
Status Recruiting
Phase
Start date November 8, 2023
Completion date October 31, 2027

See also
  Status Clinical Trial Phase
Recruiting NCT05635864 - Impact of Catheter Ablation on ABC Risk Scores
Active, not recruiting NCT04687111 - Personalised Prospective Comparison of ARni With ArB in Patients With Natriuretic Peptide eLEvation Phase 2
Not yet recruiting NCT03998956 - High-density Mapping-guided bOx Isolation and subsTrate Ablation N/A